Results 91 to 100 of about 213,213 (245)
THE CLINICAL VALUE OF THE SPIROCHÆTA PALLIDA IN THE DIAGNOSIS AND TREATMENT OF SYPHILIS. [PDF]
FREDERICK G. HARRIS
openalex +1 more source
Abstract Aims Data about long‐term clinical outcomes of revascularization procedures, especially for autologous cell therapy (ACT), in diabetic patients with chronic limb‐threatening ischaemia (CLTI) are lacking. The aim of our study was to compare the mortality and amputation rates in patients with diabetic foot ulcers (DFU) and CLTI treated by ACT ...
M. Dubský+8 more
wiley +1 more source
THE DIAGNOSIS AND TREATMENT OF "LATE" HEREDITARY SYPHILIS [PDF]
Borden S. Veeder
openalex +1 more source
Public health reforms and the mortality decline in nineteenth‐century Italy
Abstract This study examines the impact of Italy's 1887–8 health reforms on mortality, contributing to the historical debate on the state's role in Europe's health transition. Leveraging event‐study‐style difference‐in‐differences approach, we assess the effectiveness of the Crispi–Pagliani reforms, which strengthened public health governance and ...
Francesco Maria Salvatore Fiore Melacrinis+1 more
wiley +1 more source
EXPERIMENTAL OBSERVATIONS ON THE "CURE" OF SYPHILIS IN THE RABBIT WITH ARSPHENAMINE [PDF]
Alan M. Chesney, Jarold E. Kemp
openalex +1 more source
Abstract Background Recently, public health data dashboards have gained popularity as trusted, up‐to‐date sources of health information. However, their usability and usefulness may be limited. Objective To identify the requirements of usable public health data dashboards through a case study with domain experts.
Bahareh Ansari
wiley +1 more source
Characterization of ex vivo expanded natural killer cells for cancer immunotherapy
In this study, we characterized the phenotype and function of ex vivo expanded TS‐natural killer (NK) cells over a 13‐day culture period. We show dynamic cytokine secretion profiles and enhanced cytotoxicity upon coculture with tumor targets, supporting their utility in cancer immunotherapy.
Jin Young Min+5 more
wiley +1 more source